SS
XBIT icon

SBI Securities’s XBiotech XBIT Stock Holding History

SBI Securities’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Hold
37
– – ﹤0.01% 3545
2026
Q1 		$87 Buy
37
+36
+3,600% +$87 ﹤0.01% 3448
2025
Q4 		$2 Hold
1
– – ﹤0.01% 3982
2025
Q3 		$3 Hold
1
– – ﹤0.01% 4138
2025
Q2 		$3 Hold
1
– – ﹤0.01% 4108
2025
Q1 		$3 Hold
1
– – ﹤0.01% 4075
2024
Q4 		$4 Buy
+1
New +$7 ﹤0.01% 4021

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBI Securities's XBIT Position: Q2 2026 in Review

SBI Securities held its XBiotech (XBIT) position steady in Q2 2026 at 37 shares worth $85. The position accounts for ﹤0.01% of the portfolio, ranked #3545.

SBI Securities first reported a position in XBIT in Q4 2024 and has held it in 7 quarters since. The position peaked at $87 in Q1 2026. 33 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • SBI Securities held 37 shares of XBiotech worth $85 as of Q2 2026.
  • SBI Securities left its XBiotech share count unchanged in Q2 2026.
  • XBiotech made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3545 holding.
  • SBI Securities first reported a position in XBiotech in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's XBiotech position peaked at $87 in Q1 2026.
  • 33 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.